ECO Animal Health Regulatory Approval
January 22 2018 - 1:00AM
UK Regulatory
TIDMEAH
ECO Animal Health Group plc
(AIM: EAH)
ECO RECEIVES UKRANIAN MARKETING AUTHORISATIONS FOR AIVLOSIN® FOR
PIGS AND POULTRY
ECO Animal Health Group plc is pleased to announce that its
subsidiary ECO Animal Health Limited (ECO) has received a number of
marketing authorisations for Aivlosin® from the Department for Food
Safety and Veterinary from the State Service of Ukraine on Food
Safety and Consumer Protection.
Aivlosin ® , ECO's patented antimicrobial, is used for the
treatment of a variety of economically important respiratory and
enteric (gut) diseases in pigs and poultry.
These authorisations, which are for the use of Aivlosin® 625
mg/g water soluble granules and Aivlosin® 42.5 mg/g premix for both
pigs and poultry, also allow ECO to start selling Aivlosin® in the
Ukraine for the medication of drinking water or for mixing into
feed, for the treatment of infections caused by Mycoplasma in
poultry laying eggs for human consumption, with a zero day drug
withdrawal period for eggs.
These new treatments meet all the guidelines for the responsible
use of antimicrobials. Importantly, with global concerns about the
use of antibiotics in food production animals, these treatments are
under the control of veterinarians, available under prescription
only and have low, highly effective therapeutic dose rates, a short
treatment duration and a zero day or very short drug withholding
period.
Peter Lawrence, Chairman of ECO, commented "We are extremely
pleased to receive these marketing authorisations for Aivlosin® in
the Ukraine, the sixteenth largest egg producing country and one
that is ranked just outside the top twenty globally for pork
production."
The information contained within this announcement is deemed by
the Group to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR").Upon the
publication of this announcement via a Regulatory Information
Service ("RIS"), this inside information is now considered to be in
the public domain.
Contacts:
ECO Animal Health Group plc
Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
ECO Animal Health Group plc is a leader in the development,
registration and marketing of pharmaceutical products for animals.
Our products for these global growth markets promote well-being.
Our financial goals are achieved through the careful and
responsible application of science to generate value for our
shareholders
View source version on
businesswire.com:http://www.businesswire.com/news/home/20180121005079/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
January 22, 2018 02:00 ET (07:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024